Woodline Partners LP - EDGEWISE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Woodline Partners LP ownership history of EDGEWISE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,063,333
-26.1%
360,0930.0%0.02%
-27.3%
Q2 2023$2,790,721
+16.2%
360,0930.0%0.03%0.0%
Q1 2023$2,401,820
-25.4%
360,093
+0.0%
0.03%
-23.3%
Q4 2022$3,219,214
-39.4%
360,091
-33.3%
0.04%
-41.9%
Q3 2022$5,312,000
-13.5%
539,864
-30.1%
0.07%
-22.1%
Q2 2022$6,144,000
+75.9%
771,797
+114.3%
0.10%
+66.7%
Q1 2022$3,493,000
-43.3%
360,093
-10.6%
0.06%
-35.2%
Q4 2021$6,156,000
+2.5%
402,849
+11.3%
0.09%
-10.2%
Q3 2021$6,006,000
-20.6%
361,821
+2.1%
0.10%
-30.5%
Q2 2021$7,561,000
-34.9%
354,489
-0.8%
0.14%
-45.3%
Q1 2021$11,616,000357,4290.26%
Other shareholders
EDGEWISE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,553,661$50,494,00011.75%
Novo Holdings A/S 5,587,207$181,584,0007.50%
Orbimed Advisors 13,944,680$453,202,0004.24%
Logos Global Management LP 1,056,812$34,346,0003.35%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,933,137$127,827,0002.69%
EcoR1 Capital, LLC 1,224,175$39,786,0001.76%
Cormorant Asset Management, LP 2,340,914$74,307,0001.66%
Octagon Capital Advisors LP 125,000$4,063,0001.53%
RA Capital Management 2,613,623$84,943,0001.28%
Soleus Capital Management, L.P. 100,000$3,250,0000.59%
View complete list of EDGEWISE THERAPEUTICS INC shareholders